-
Pitt and Bayer to advance research for heart, lung and blood disease indications
pharmaceutical-technology
January 13, 2017
The University of Pittsburgh (Pitt) and Bayer have collaborated to advance research for heart, lung and blood disease indications.
-
New study finds antidepressant use increases hip fracture risk in people with Alzheimer’s disease
pharmaceutical-technology
January 13, 2017
A new study from the University of Eastern Finland has found that the use of antidepressants nearly doubles the risk of hip fracture among community-dwelling people with Alzheimer’s disease.
-
Phase II trial for F2G’s antifungal drug following EU approval
europeanpharmaceuticalreview
January 13, 2017
The European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted orphan drug status to UK biotech firm F2G’s lead clinical candidate, F901318, for the treatment of invasive Aspergillosis and rare mould infections caused by Scedospor
-
Govt to soon come out with clarifications on online sale of medicines
financialexpress
January 13, 2017
E-pharmacy players, in recent months, have come under attack from off-line chemist stores that allege that the former are violating foreign direct investment (FDI) rules by offering discounts
-
NHS Confederation appoints Niall Dickson as new Chief Executive
europeanpharmaceuticalreview
January 13, 2017
The NHS Confederation today announced the appointment of Niall Dickson as its new Chief Executive.
-
Lupin gets US FDA nod to market its skin cream
financialexpress
January 13, 2017
The products to be marketed are generic versions of Taro’s Topicort Emollient cream, 0.05 per cent and Topicort cream, 0.25 per cent
-
Shionogi Announces Positive Top-Line Results for Cefiderocol Pivotal cUTI Clinical Trial
americanpharmaceuticalreview
January 13, 2017
Shionogi & Co. has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for non-inferiority vs imipenem/cilastatin (IPM/CS) in patients with serious complicated urin
-
Measles-rubella vaccine to roll out in February
financialexpress
January 13, 2017
Commonly known as German Measles, congenital rubella infection is believed to affect approximately 25,000 children born in India every year
-
PIQUR and PIERRE FABRE Announce Partnership in Dermato-Oncology
americanpharmaceuticalreview
January 13, 2017
PIQUR Therapeutics AG, a Swiss clinical-stage pharmaceutical company, and Pierre Fabre, the second largest private French pharmaceutical group have signed a collaboration agreement for the development of PIQUR's lead compound PQR309 in dermato-oncology.
-
Merck Licenses Four Oncology Research and Development Programs from Vertex
americanpharmaceuticalreview
January 13, 2017
Merck KGaA, Darmstadt, Germany, a science and technology company which operates its biopharmaceutical business in the US and Canada as EMD Serono, has entered into a licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA, for the